The Department of Veterans Affairs (VA) Strategic Acquisition Center awarded a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract for the procurement of various types of biologics and biological implants, including allografts from human cadavers and xenografts from animals. The contract aims to provide these products for use in surgeries and medical procedures at VA facilities. The contract has a one-year base period with four one-year options, and the total potential value is $4,206,786,653.28. The prime contractor is Physiorx, LLC, a woman-owned small business. The contract is not set-aside. The biologics and implants must be FDA-approved and tracked from source to implantation, labeled in accordance with ISBT 128 standards. The evaluation criteria included technical compliance, pricing, and subcontracting plans. The original solicitation was posted on FBO.gov, with a draft RFP published on December 15, 2017, and the final RFP expected on December 31, 2017. Proposals were due periodically through November 2018, and the government anticipated awarding up to 30 contracts worth a total of $2.1 billion over five years.
Generated 4/19/24, 9:22 AM